| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9104996 | Bone | 2005 | 10 Pages |
Abstract
Because bone cell abnormalities in Nf1 haploinsufficiency were detected in vitro, redundant pathways must compensate for the deregulation of Ras signaling in vivo to maintain normal bone mass and function in vivo. Our in vitro data revealed that neurofibromin and its control of Ras signaling are required for osteoprogenitor homeostasis.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
X. Yu, S. Chen, O.L. Potter, S.M. Murthy, J. Li, J.M. Pulcini, N. Ohashi, T. Winata, E.T. Everett, D. Ingram, W.D. Clapp, J.M. Hock,